Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.

@article{Maron2000EfficacyOI,
  title={Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.},
  author={Barry Joel Maron and Win K. Shen and Mark S. Link and Andrew E. Epstein and Adrian K. Almquist and James P Daubert and Gust H. Bardy and Stefano Favale and Robert F. Rea and Guiseppe Boriani and N. A. Mark Estes and P. Spirito},
  journal={The New England journal of medicine},
  year={2000},
  volume={342 6},
  pages={365-73}
}
BACKGROUND Hypertrophic cardiomyopathy is a genetic disease associated with a risk of ventricular tachyarrhythmias and sudden death, especially in young patients. METHODS We conducted a retrospective multicenter study of the efficacy of implantable cardioverter-defibrillators in preventing sudden death in 128 patients with hypertrophic cardiomyopathy who were judged to be at high risk for sudden death. RESULTS At the time of the implantation of the defibrillator, the patients were 8 to 82… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 250 extracted citations

Hypertrophische Kardiomyopathie

Herz Kardiovaskuläre Erkrankungen • 2005
View 4 Excerpts
Highly Influenced

Therapie und Risikostratifizierung der Hypertrophen Kardiomyopathie

Zeitschrift für Kardiologie • 2003
View 8 Excerpts
Highly Influenced

Schrittmacher-Stimulation in der Behandlung der hypertrophisch obstruktiven Kardiomyopathie

Herzschrittmachertherapie und Elektrophysiologie • 2004
View 17 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…